SE8702734D0 - MONOCLONAL ANTIBODIES TO PSEUDOMONAS AERUGINOSA FLAGELLA - Google Patents
MONOCLONAL ANTIBODIES TO PSEUDOMONAS AERUGINOSA FLAGELLAInfo
- Publication number
- SE8702734D0 SE8702734D0 SE8702734A SE8702734A SE8702734D0 SE 8702734 D0 SE8702734 D0 SE 8702734D0 SE 8702734 A SE8702734 A SE 8702734A SE 8702734 A SE8702734 A SE 8702734A SE 8702734 D0 SE8702734 D0 SE 8702734D0
- Authority
- SE
- Sweden
- Prior art keywords
- monoclonal antibodies
- pseudomonas aeruginosa
- antibodies
- aeruginosa flagella
- flagella
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Cell lines have been produced that secrete monoclonal antibodies which bind to the flagellar proteins of selected Pseudomonas aeruginosa strains. Some of these antibodies have been found to be protective against lethal challenges of P. aeruginosa. Pharmaceutical compositions containing these antibodies, can be used singly or in combination with other monoclonal antibodies, blood plasma fractions and antimicrobial agents, to form prophylactic and therapeutic compositions. <IMAGE>
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88198486A | 1986-07-03 | 1986-07-03 | |
US06/946,554 US4834976A (en) | 1986-07-03 | 1986-12-24 | Monoclonal antibodies to pseudomonas aeruginosa flagella |
US4814387A | 1987-05-15 | 1987-05-15 |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8702734D0 true SE8702734D0 (en) | 1987-07-02 |
SE8702734L SE8702734L (en) | 1988-01-04 |
SE506421C2 SE506421C2 (en) | 1997-12-15 |
Family
ID=27367280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8702734A SE506421C2 (en) | 1986-07-03 | 1987-07-02 | Monoclonal antibodies to Pseudomonas aeruginosa and preparations containing them, test kit containing the preparation, and cell lines expressing the antibodies |
Country Status (19)
Country | Link |
---|---|
JP (1) | JP2639422B2 (en) |
KR (1) | KR910002373B1 (en) |
AT (1) | AT399885B (en) |
AU (1) | AU615162B2 (en) |
BE (1) | BE1000743A3 (en) |
CH (1) | CH677796A5 (en) |
DE (1) | DE3722098C2 (en) |
DK (1) | DK172840B1 (en) |
ES (1) | ES2013321A6 (en) |
FR (1) | FR2601458B1 (en) |
GB (1) | GB2192185B (en) |
IE (1) | IE60888B1 (en) |
IL (1) | IL83047A (en) |
IT (1) | IT1221940B (en) |
LU (1) | LU86938A1 (en) |
NL (1) | NL194961C (en) |
OA (1) | OA08629A (en) |
PT (1) | PT85247B (en) |
SE (1) | SE506421C2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4772464A (en) * | 1985-08-01 | 1988-09-20 | Miles Laboratories, Inc. | Protective antibodies to serotypic determinants of flagellar antigens |
NZ218499A (en) * | 1985-12-10 | 1990-04-26 | Genetic Systems Corp | Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods |
AU615162B2 (en) * | 1986-07-03 | 1991-09-26 | Genetic Systems Corporation | Monoclonal antibodies to pseudomonas aeruginosa flagella |
CA1341375C (en) * | 1988-10-12 | 2002-07-09 | Baxter International Inc. | Compositions and methods for the treatment and prevention of gram-negative bacterial infections |
JPH02299594A (en) * | 1989-01-30 | 1990-12-11 | Sumitomo Chem Co Ltd | Human monoclonal antibodies and their production method |
AU5525490A (en) * | 1989-04-14 | 1990-11-16 | Biocontrol Systems, Incorporated | Process and device for detecting a particular motile organism |
CA2073855C (en) * | 1990-01-18 | 2007-04-24 | Bill Elliot Cham | Glycoalkaloids for controlling cellular autophagy |
US20100272736A1 (en) * | 2009-02-04 | 2010-10-28 | Kalobios Pharmaceuticals, Inc. | Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection |
EP2542577A1 (en) * | 2010-03-01 | 2013-01-09 | Lostam Biopharmaceuticals Ltd | Improved therapeutic antibodies against flagellated pseudomonas aeruginosa |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8422649D0 (en) * | 1984-09-07 | 1984-10-10 | Technology Licence Co Ltd | Monoclonal antibodies |
JP2691708B2 (en) * | 1984-09-26 | 1997-12-17 | 住友製薬株式会社 | Human monoclonal antibody and method for producing the same |
HU205630B (en) * | 1985-06-06 | 1992-05-28 | Genetic Systems Corp | Process for producing monoclonal antibodys inhibiting exotoxine and toxic effect of pseudomonas aeruginosa and specific for them, celle lines producing them and pharmaceutical compositions |
DE3689713T2 (en) * | 1985-08-01 | 1994-07-07 | Miles Inc | Protective antibodies against serotypic determinants of flagellar antigens. |
US4918163A (en) * | 1985-09-27 | 1990-04-17 | Pfizer Inc. | Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria |
NZ218499A (en) * | 1985-12-10 | 1990-04-26 | Genetic Systems Corp | Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods |
ZA868673B (en) * | 1985-12-10 | 1988-07-27 | Genetic Systems Corp | Monoclonal antibodies cross-reactive and cross-protective against p.aeruginosa serotypes |
AU615162B2 (en) * | 1986-07-03 | 1991-09-26 | Genetic Systems Corporation | Monoclonal antibodies to pseudomonas aeruginosa flagella |
-
1987
- 1987-06-30 AU AU74958/87A patent/AU615162B2/en not_active Expired
- 1987-06-30 DK DK198703366A patent/DK172840B1/en not_active IP Right Cessation
- 1987-06-30 GB GB8715347A patent/GB2192185B/en not_active Expired - Lifetime
- 1987-07-01 IL IL83047A patent/IL83047A/en not_active IP Right Cessation
- 1987-07-02 SE SE8702734A patent/SE506421C2/en not_active IP Right Cessation
- 1987-07-02 JP JP62166234A patent/JP2639422B2/en not_active Expired - Lifetime
- 1987-07-02 NL NL8701554A patent/NL194961C/en not_active IP Right Cessation
- 1987-07-02 IE IE176987A patent/IE60888B1/en not_active IP Right Cessation
- 1987-07-02 IT IT21163/87A patent/IT1221940B/en active
- 1987-07-02 ES ES878701936A patent/ES2013321A6/en not_active Expired - Fee Related
- 1987-07-02 FR FR878709370A patent/FR2601458B1/en not_active Expired - Lifetime
- 1987-07-03 KR KR1019870007069A patent/KR910002373B1/en not_active IP Right Cessation
- 1987-07-03 OA OA59157A patent/OA08629A/en unknown
- 1987-07-03 BE BE8700743A patent/BE1000743A3/en not_active IP Right Cessation
- 1987-07-03 AT AT0168387A patent/AT399885B/en not_active IP Right Cessation
- 1987-07-03 PT PT85247A patent/PT85247B/en unknown
- 1987-07-03 LU LU86938A patent/LU86938A1/en unknown
- 1987-07-03 CH CH2545/87A patent/CH677796A5/de not_active IP Right Cessation
- 1987-07-03 DE DE3722098A patent/DE3722098C2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200301159A1 (en) | Cytotoxic Immunoconjugates Antibodies to CD44 | |
SE8700498D0 (en) | NOVEL PHARMACEOLOGICALLY ACTIVE COMPOUNDS | |
EA199800946A1 (en) | CONCENTRATED ANTIBODY PREPARATION | |
CY1105349T1 (en) | THIAZOLYL TEC FAMILY TYROKINASE INHIBITORS | |
SE8605295D0 (en) | MONOCLONAL ANTIBODIES CROSS-REACTIVE AND CROSSPROTECTIVE AGAINST P. AERUGINOSA SEROTYPES | |
ES2062355T3 (en) | PHARMACEUTICAL COMPOSITION INCLUDING LORATADINE, IBUPROPHEN AND PSEUDOEFEDRINE. | |
NO964966D0 (en) | Lactobacillus strains of human origin, mixtures and their use | |
DE69530763D1 (en) | ANTIBODIES AGAINST E-SELECTECT | |
DK0817847T3 (en) | IL-17 receptor | |
NO962346L (en) | Humanized antibodies and uses thereof | |
AR004357A1 (en) | 1-PHENYL-2-DIMETHYLAMINOMETHYL-CYCLOHEXAN-1-OL COMPOUNDS, AND PREPARATION PROCEDURE FOR SUCH COMPOUNDS. | |
DK250181A (en) | PROCEDURE FOR THE PREPARATION OF WINE BLAST INGREDIENTS | |
GR1000118B (en) | Composition 1,2-dioetans and intermediate substances for it | |
DK0858504T3 (en) | Diagnostic remedies and treatments for periodontal diseases | |
SE8702734D0 (en) | MONOCLONAL ANTIBODIES TO PSEUDOMONAS AERUGINOSA FLAGELLA | |
DK0610286T3 (en) | Recombinant immunotoxins | |
NO921382D0 (en) | AMIDINOPHENYLALANINE DERIVATIVES, AS PREPARATION, USE AND PREPARATIONS CONTAINING THE COMPOUNDS | |
DE69426767D1 (en) | Anti idiotypic antibodies to gonococci and methods and compositions using them. | |
ES2132556T3 (en) | NEW DERIVATIVE OF BENZO-TIADIAZINA, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT. | |
ATE188873T1 (en) | TRIS PLATINUM COMPLEXES | |
EA200400670A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING 3,4-PROPINOPPERHYDROPURINS AND THEIR APPLICATION FOR BLOCKING NEURAL TRANSMISSION | |
AU584690B2 (en) | E87ag antigen of pseudomonas aeruginosa, monoclonal antibody against it, and hybridoma | |
IE861494L (en) | Protective human monoclonal antibodies to pseudomonas¹aeruginosa exotoxin a | |
DK52080A (en) | DEHYDROPEPTIDES PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS MEDICINES | |
DK319384D0 (en) | 1-0-ALKYL-3-AMINO-PROPAN-1,2-DIOL-2-0-PHOSPHOLIPIDES, PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |